Crescita Therapeutics Revenue vs. Operating Margin
| CRRTF Stock | USD 0.45 0.00 0.00% |
For Crescita Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Crescita Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Crescita Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Crescita Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Crescita Therapeutics over time as well as its relative position and ranking within its peers.
Crescita |
Crescita Therapeutics Operating Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Crescita Therapeutics's current stock value. Our valuation model uses many indicators to compare Crescita Therapeutics value to that of its competitors to determine the firm's financial worth. Crescita Therapeutics is the top company in revenue category among its peers. It also is number one stock in operating margin category among its peers . The ratio of Revenue to Operating Margin for Crescita Therapeutics is about 416,104,218 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Crescita Therapeutics' earnings, one of the primary drivers of an investment's value.Crescita Revenue vs. Competition
Crescita Therapeutics is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 57.47 Million. Crescita Therapeutics totals roughly 16.77 Million in revenue claiming about 29% of equities under Health Care industry.
Crescita Operating Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Crescita Therapeutics |
| = | 16.77 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Crescita Therapeutics |
| = | 0.04 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Crescita Operating Margin Comparison
Crescita Therapeutics is currently under evaluation in operating margin category among its peers.
Crescita Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Crescita Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Crescita Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Crescita Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Crescita Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.
Crescita Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Crescita Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Crescita Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Crescita Therapeutics' important profitability drivers and their relationship over time.
Use Crescita Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescita Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will appreciate offsetting losses from the drop in the long position's value.Crescita Therapeutics Pair Trading
Crescita Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Crescita Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescita Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescita Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescita Therapeutics to buy it.
The correlation of Crescita Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescita Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescita Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescita Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Crescita Therapeutics position
In addition to having Crescita Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Crescita Pink Sheet
To fully project Crescita Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Crescita Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Crescita Therapeutics' income statement, its balance sheet, and the statement of cash flows.